ArticleBMC medicine2026

Mitoxantrone hydrochloride liposome (Lipo-MIT) combined with capecitabine in HER2-negative advanced breast cancer: a dose-escalation, phase I study.

Jiaxuan Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.